Xpert MTB/RIF and GenoType MTBDRplus assays for the rapid diagnosis of bone and joint tuberculosis | Zendy

Yunting Gu | Zendy; Guirong Wang | Zendy; Weijie Dong | Zendy; Yunxu Li | Zendy; Yifeng Ma | Zendy; Yuanyuan Shang | Zendy; Shibing Qin | Zendy; Hairong Huang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Xpert MTB/RIF and GenoType MTBDRplus assays for the rapid diagnosis of bone and joint tuberculosis

Author(s) -

Yunting Gu,

Guirong Wang,

Weijie Dong,

Yunxu Li,

Yifeng Ma,

Yuanyuan Shang,

Shibing Qin,

Hairong Huang

Publication year - 2015

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2015.05.014

Subject(s) - medicine , extrapulmonary tuberculosis , rifampicin , tuberculosis , drug resistance , mycobacterium tuberculosis , pathology , microbiology and biotechnology , biology

Bone and joint tuberculosis (BJTB) constitutes about 10-20% of the extrapulmonary tuberculosis (EPTB) cases in China. The GenoType MTBDRplus assay (MTBDR) has been endorsed by the World Health Organization (WHO) for the diagnosis of pulmonary TB (PTB), while the Xpert MTB/RIF assay (Xpert) has also been endorsed by the WHO for the diagnosis of both PTB and EPTB. The diagnostic utility of these two techniques for BJTB was investigated prospectively.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research